Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.

Thomas KH, Martin RM, Davies NM, Metcalfe C, Windmeijer F, Gunnell D.

BMJ. 2013 Oct 11;347:f5704. doi: 10.1136/bmj.f5704.

2.

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

Gunnell D, Irvine D, Wise L, Davies C, Martin RM.

BMJ. 2009 Oct 1;339:b3805. doi: 10.1136/bmj.b3805.

3.

Suicidal behavior and depression in smoking cessation treatments.

Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S.

PLoS One. 2011;6(11):e27016. doi: 10.1371/journal.pone.0027016.

4.

Varenicline, smoking cessation, and neuropsychiatric adverse events.

Gibbons RD, Mann JJ.

Am J Psychiatry. 2013 Dec;170(12):1460-7. doi: 10.1176/appi.ajp.2013.12121599.

5.

Still not clear that smoking cessation drugs do not cause psychiatric symptoms.

Davies SP.

BMJ. 2013 Nov 27;347:f7065. doi: 10.1136/bmj.f7065. No abstract available.

PMID:
24285169
6.

Authors' reply to Davies.

Thomas KH, Martin RM, Davies NM, Metcalfe C, Windmeijer F, Gunnell D.

BMJ. 2013 Nov 27;347:f7068. doi: 10.1136/bmj.f7068. No abstract available.

PMID:
24285170
7.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
8.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
9.

'Real-world' effectiveness of smoking cessation treatments: a population study.

Kotz D, Brown J, West R.

Addiction. 2014 Mar;109(3):491-9. doi: 10.1111/add.12429.

PMID:
24372901
10.

[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].

Sicras Mainar A, Navarro Artieda R, Díaz Cerezo S, Martí Sánchez B, Sanz De Burgoa V.

Aten Primaria. 2011 Sep;43(9):482-9. doi: 10.1016/j.aprim.2010.09.010. Spanish.

11.

Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.

Graham DJ, By K, McKean S, Mosholder A, Kornegay C, Racoosin JA, Young J, Levenson M, MaCurdy TE, Worrall C, Kelman JA.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1205-12. doi: 10.1002/pds.3678.

PMID:
25044169
12.

What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study.

Davies NM, Taylor G, Taylor AE, Thomas KH, Windmeijer F, Martin RM, Munafò MR.

BMJ Open. 2015 Nov 5;5(11):e009665. doi: 10.1136/bmjopen-2015-009665.

13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
15.

Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.

Svanström H, Pasternak B, Hviid A.

BMJ. 2012 Nov 8;345:e7176. doi: 10.1136/bmj.e7176.

17.

General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.

Johnson M, Anderson P, Lockhart I.

BMC Fam Pract. 2014 Mar 20;15:47. doi: 10.1186/1471-2296-15-47.

18.

Prescribing of smoking cessation medication in England since the introduction of varenicline.

Langley TE, Huang Y, McNeill A, Coleman T, Szatkowski L, Lewis S.

Addiction. 2011 Jul;106(7):1319-24. doi: 10.1111/j.1360-0443.2011.03426.x.

PMID:
21395894
19.

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):35-43. doi: 10.3810/hp.2012.02.946.

PMID:
22406881
20.

Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.

Cinciripini PM, Robinson JD, Karam-Hage M, Minnix JA, Lam C, Versace F, Brown VL, Engelmann JM, Wetter DW.

JAMA Psychiatry. 2013 May;70(5):522-33. doi: 10.1001/jamapsychiatry.2013.678.

Items per page

Supplemental Content

Support Center